The biotech bi-weekly: protein quantification, AMR mutation characterization and automating single-cell transcriptomics
The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations associated with antimicrobial resistance (AMR), to automating single-cell transcriptomics and launching an innovative PFAS startup, it has certainly been an exciting time for the biotech industry. Products Quantifying His-tagged proteins Abselion (Cambridge, UK), a life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the launch of its Tagged Protein Quantification Kit. The novel assay, developed with GenScript’s (NJ, USA) THE™ His Tag Monoclonal Antibodies, provides researchers with a ready-to-use...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!